FDA approves NPS Natpara drug to treat rare hormone disorder Hypoparathyroidism
NPS Pharmaceuticals Inc.’s hormone drug, Natpara, has received authorization for sale from the U.S. Food and Drug Administration. Natpara is aimed at treating hypoparathyroidism, which is a rare kind of a hormo...